The Effect of Bifocals in Children With Down Syndrome

March 12, 2020 updated by: Radboud University Medical Center
Visual acuity at near improves in children with Down syndrome using bifocals

Study Overview

Detailed Description

The accommodation is consistently reduced in 50 to 100% of children with Down syndrome and does not improve with age.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Overijssel
      • Zwolle, Overijssel, Netherlands, 8025 AB
        • Isala Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 14 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosed with Down syndrome (DS)
  • Accommodation lag >0.5 Dioptres for children with DS <12 years and >0.75 Dioptres for children older than age 12 or Visual acuity at near is worse than at distance and >0.1
  • Age range 2-14 years
  • Speaks Dutch as the first language
  • Must be verbal or able to understand instructions
  • Must be able to perform a task sitting on a chair and working at a table

Exclusion Criteria:

  • Visual acuity at near < 0.1
  • Not able to do vision tests at age over 5
  • Has worn bifocals already
  • Other significant eye diseases, such as keratoconus, cataract or high myopia (>S-6.00).
  • Diagnoses of any neurological, sensory or behavioural disorders such as autism, microcephaly or significant hearing loss.
  • Prematurity, born premature after a pregnancy term less than 36 weeks
  • Born after severe perinatal problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: single vision glasses
single vision glasses
Experimental: bifocals
bifocal glasses
bifocal glasses with an addition of 2.5 Dioptres
Other Names:
  • bifocal glasses
  • reading glasses

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
• Change from baseline in visual acuity at near measured in decimals and in Logarithm of the Minimum Angle of Resolution (LogMAR) at 16 months.
Time Frame: baseline to 12 months later
visual acuity is measured in decimals and in Logarithm of the Minimum Angle of Resolution (LogMAR) at baseline and at the end of the study 16 months later. We will calculate the difference.
baseline to 12 months later

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
• Visual acuity at near measured in decimals and in Logarithm of the Minimum Angle of Resolution (LogMAR) at 16 months.
Time Frame: after 12 months
visual acuity at near measured in decimals and in Logarithm of the Minimum Angle of Resolution (LogMAR) at 16 months.
after 12 months
• Change from baseline in visual acuity at distance measured in decimals and in Logarithm of the Minimum Angle of Resolution (LogMAR) at 16 months.
Time Frame: baseline to 12 months later
Visual acuity at distance is measured in decimals and in Logarithm of the Minimum Angle of Resolution (LogMAR) at baseline and at the end of the study 16 months later. We will calculate the difference.
baseline to 12 months later
• Change from baseline in accuracy of accommodation response measured in Dioptres.
Time Frame: baseline to 12 months later
We will measure the accuracy of accommodation in Dioptres at baseline and after 16 months. We will calculate the difference.
baseline to 12 months later
• Change in percentage of participants with strabismus
Time Frame: baseline to 12 months later
We will calculate the percentage of participants with strabismus at baseline and at the end of the study, 16 months later. Then we can calculate the difference in percentage of participants with strabismus.
baseline to 12 months later
• Change in score of task readiness of the children
Time Frame: baseline to 12 months later
We will measure task readiness in scores of attention, reaction time, inhibition and working memory at baseline and at the end of the study 16 months later. Then we calculate the difference in this score.
baseline to 12 months later

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
• Possible prognostic determinants at baseline for improvement of visual acuity at near
Time Frame: participants will be followed for the duration of 12 months, after the last included participant has been followed up for 18 months we will do this analysis
Applying a multivariate logistic regression model using a backward variable elimination procedure (selection criterion P < 0.05, removal criterion P < 0.10) to test a key set of independent prognostic variables (measured at baseline) for better visual acuity at near after 12 months
participants will be followed for the duration of 12 months, after the last included participant has been followed up for 18 months we will do this analysis

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: H HL Goossens, PhD, Radboudumc, Dept. Cognitive Neuroscience/126

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

June 1, 2017

Study Registration Dates

First Submitted

August 29, 2014

First Submitted That Met QC Criteria

September 15, 2014

First Posted (Estimate)

September 16, 2014

Study Record Updates

Last Update Posted (Actual)

March 16, 2020

Last Update Submitted That Met QC Criteria

March 12, 2020

Last Verified

March 1, 2020

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Visual Acuity at Near

Clinical Trials on single vision glasses

Subscribe